Uridine adenosine tetraphosphate (Up 4A) is a strong inductor of smooth muscle cell migration via activation of the P2Y 2 receptor and cross-communication to the PDGF receptor

Biochemical and Biophysical Research Communications

Volumn 417, Issue 3, 2012, Pages 1035-1040

  Wiedon, Annette ^a   Tölle, Markus ^a   Bastine, Joschika ^a   Schuchardt, Mirjam ^a   Huang, Tao ^a   Jankowski, Vera ^a   Jankowski, Joachim ^a   Zidek, Walter ^a   Van Der Giet, Markus ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atherosclerosis; Dinucleotide; Migration; Osteopontin; P2Y; PDGF receptor transactivation; Purinoceptors; Up 4a; Vascular smooth muscle cells

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOPONTIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PURINERGIC P2Y2 RECEPTOR; SURAMIN; UNCLASSIFIED DRUG; URIDINE; URIDINE ADENOSINE TETRAPHOSPHATE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL COMMUNICATION; CELL MIGRATION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DINUCLEOSIDE PHOSPHATES; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCYTES, SMOOTH MUSCLE; RATS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTORS, PURINERGIC P2Y2; RNA, SMALL INTERFERING; TYRPHOSTINS;

EID: 84856000824     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.12.088     Document Type: Article

References (32)

1. Jankowski V., Tölle M., Vanholder R., Schonfelder G., van der Giet M., Henning L., Schluter H., Paul M., Zidek W., Jankowski J. Uridine adenosine tetraphosphate: a novel endothelium-derived vasoconstrictive factor. Nat. Med. 2005, 11:223-227.
2. Tölle M., Schuchardt M., Wiedon A., Huang T., Klöckl L., Jankowski J., Jankowski V., Zidek W., van der Giet M. Differential effects of uridine adenosine tetraphosphate on purinoceptors in the rat isolated perfused kidney. Br. J. Pharmacol. 2010, 161:530-540.
3. Jankowski V., Meyer A.A., Schlattmann P., Gui Y., Zheng X.L., Stamcou I., Radtke K., Tran T.N., van der Giet M., Tölle M., Zidek W., Jankowski J. Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives. Arterioscler. Thromb. Vasc. Biol. 2007, 27:1776-1781.
4. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
5. Casscells W. Migration of smooth muscle and endothelial cells. Critical events in restenosis. Circulation 1992, 86:723-729.
6. Newby A.C., Zaltsman A.B. Fibrous cap formation or destruction - the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Cardiovasc. Res. 1999, 41:345-360.
7. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ. Res. 2007, 100:607-621.
8. Chaulet H., Desgranges C., Renault M.A., Dupuch F., Ezan G., Peiretti F., Loirand G., Pacaud P., Gadeau A.P. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ. Res. 2001, 89:772-778.
9. Mediero A., Peral A., Pintor J. Dual roles of diadenosine polyphosphates in corneal epithelial cell migration. Invest. Ophthalmol. Vis. Sci. 2006, 47:4500-4506.
10. Scatena M., Liaw L., Giachelli C.M. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2302-2309.
11. Liaw L., Almeida M., Hart C.E., Schwartz S.M., Giachelli C.M. Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Circ. Res. 1994, 74:214-224.
12. Jalvy S., Renault M.A., Lam Shang Leen L., Belloc I., Reynaud A., Gadeau A.P., Desgranges C. CREB mediates utp-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites. Circ. Res. 2007, 100:1292-1299.
13. Boström K. Osteopontin, a missing link in PDGF-induced smooth muscle cell migration. Cardiovasc. Res. 2007, 75:634-635.
14. Jalvy S., Renault M.A., Leen L.L., Belloc I., Bonnet J., Gadeau A.P., Desgranges C. Autocrine expression of osteopontin contributes to PDGF-mediated arterial smooth muscle cell migration. Cardiovasc. Res. 2007, 75:738-747.
15. Raines E.W. PDGF and cardiovascular disease. Cytokine Growth Factor Rev. 2004, 15:237-254.
16. Jackson C.L., Raines E.W., Ross R., Reidy M.A. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arterioscler. Thromb. 1993, 13:1218-1226.
17. Hellstrom M., Kalen M., Lindahl P., Abramsson A., Betsholtz C. Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development. 1999, 126:3047-3055.
18. Schuchardt M., Prüfer J., Prüfer N., Wiedon A., Huang T., Chebli M., Jankowski V., Jankowski J., Schäfer-Korting M., Zidek W., van der Giet M., Tölle M. The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y(2)-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation. J. Mol. Med. 2011, 89:799-810.
19. M. Schuchardt, M. Tölle, J. Prüfer, N. Prüfer, T. Huang, V. Jankowski, J. Jankowski, W. Zidek, M. van der Giet, Uridine adenosine tetraphosphate activation of the purinergic receptor P2Y enhances in vitro vascular calcification, Kidney Int., 2011. doi:10.1038/ki.2011.326.
20. Chen S.W., Chen Y.X., Zhang X.R., Qian H., Chen W.Z., Xie W.F. Targeted inhibition of platelet-derived growth factor receptor-beta subunit in hepatic stellate cells ameliorates hepatic fibrosis in rats. Gene Ther. 2008, 15:1424-1435.
21. von Kügelgen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Ther. 2006, 110:415-432.
22. Soltoff S.P., Avraham H., Avraham S., Cantley L.C. Activation of P2Y2 receptors by UTP and ATP stimulates mitogen-activated kinase activity through a pathway that involves related adhesion focal tyrosine kinase and protein kinase c. J. Biol. Chem. 1998, 273:2653-2660.
23. Erlinge D., Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008, 4:1-20.
24. Communi D., Janssens R., Suarez-Huerta N., Robaye B., Boeynaems J.M. Advances in signalling by extracellular nucleotides. The role and transduction mechanisms of P2Y receptors. Cell. Signal. 2000, 12:351-360.
25. Wilden P.A., Agazie Y.M., Kaufman R., Halenda S.P. ATP-stimulated smooth muscle cell proliferation requires independent ERK and PI3K signaling pathways. Am. J. Physiol. 1998, 275:H1209-1215.
26. Renault M.A., Jalvy S., Potier M., Belloc I., Genot E., Dekker L.V., Desgranges C., Gadeau A.P. UTP induces osteopontin expression through a coordinate action of NFkappaB, activator protein-1, and upstream stimulatory factor in arterial smooth muscle cells. J. Biol. Chem. 2005, 280:2708-2713.
27. Bornfeldt K.E., Raines E.W., Graves L.M., Skinner M.P., Krebs E.G., Ross R. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann. N. Y. Acad. Sci. 1995, 766:416-430.
28. Peppel K., Zhang L., Orman E.S., Hagen P.O., Amalfitano A., Brian L., Freedman N.J. Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms. Cardiovasc. Res. 2005, 65:674-682.
29. Delcourt N., Bockaert J., Marin P. GPCR-jacking: from a new route in RTK signalling to a new concept in GPCR activation. Trends Pharmacol. Sci. 2007, 28:602-607.
30. Ratchford A.M., Baker O.J., Camden J.M., Rikka S., Petris M.J., Seye C.I., Erb L., Weisman G.A. P2Y2 nucleotide receptors mediate metalloprotease-dependent phosphorylation of epidermal growth factor receptor and rrbb3 in human salivary gland cells. J. Biol. Chem. 2010, 285:7545-7555.
31. Liu J., Liao Z., Camden J., Griffin K.D., Garrad R.C., Santiago-Perez L.I., Gonzalez F.A., Seye C.I., Weisman G.A., Erb L. Src homology 3 binding sites in the P2Y2 nucleotide receptor interact with src and regulate activities of src, proline-rich tyrosine kinase 2, and growth factor receptors. J. Biol. Chem. 2004, 279:8212-8218.
32. Jankowski V., Gunthner T., Herget-Rosenthal S., Zidek W., Jankowski J. Dinucleoside polyphosphates and uremia. Semin. Dialysis 2009, 22:396-399.